Remarkable response with pembrolizumab plus albumin-bound paclitaxel in 2 cases of HER2-positive metastatic breast cancer who have failed to multi-anti-HER2 targeted therapy

.


from Cancer via ola Kala on Inoreader http://ift.tt/2DoiXJr
via IFTTT